Beijing Hotgen Biotech Co Ltd
SSE:688068
Beijing Hotgen Biotech Co Ltd
Depreciation & Amortization
Beijing Hotgen Biotech Co Ltd
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Beijing Hotgen Biotech Co Ltd
SSE:688068
|
Depreciation & Amortization
-¥59.5m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-44%
|
CAGR 10-Years
N/A
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Depreciation & Amortization
-¥37.1m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Genscript Biotech Corp
HKEX:1548
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Beijing Hotgen Biotech Co Ltd's Depreciation & Amortization?
Depreciation & Amortization
-59.5m
CNY
Based on the financial report for Dec 31, 2022, Beijing Hotgen Biotech Co Ltd's Depreciation & Amortization amounts to -59.5m CNY.
What is Beijing Hotgen Biotech Co Ltd's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
-44%
Over the last year, the Depreciation & Amortization growth was -44%. The average annual Depreciation & Amortization growth rates for Beijing Hotgen Biotech Co Ltd have been -47% over the past three years , -44% over the past five years .